RAD receives approval for Phase 1 therapeutic study of PDL1-nanobody in Non-Small Cell Lung Cancer

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Rite Aid Receives Court Approval of "First Day" Motions to Support Business Operations
Rite Aid Corporation Appoints Jeffrey S. Stein Chief Executive Officer
Rite Aid Takes Steps to Accelerate Transformation and Position Company for Long-Term Success
CORRECTING and REPLACING Creep It Simple: Rite Aid Releases DIY Halloween Costume Recipe Cards
Creep It Simple: Rite Aid Releases DIY Halloween Costume Recipe Cards
Rite Aid Helps Families Prep for Fall the Rite Way with Family Immunization Day
Rite Aid Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Standards
Rite Aid Invites Customers to 'Live flavorably!(TM)' with Launch of Ello Market

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.